Skip to content

Drug interactions

Fosamprenavir + Insulin glargine-lixisenatide

Severity: Moderate

Fosamprenavir and Insulin glargine-lixisenatide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

HIV protease inhibitors can cause insulin resistance and hyperglycemia, which may reduce the glucose-lowering effect of insulin glargine and lixisenatide. Glycemic control may worsen, particularly early in treatment.

What this interaction means in plain words

Fosamprenavir and Insulin glargine-lixisenatide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Moderate

Why it happens

Protease inhibitors impair insulin-mediated glucose uptake, partly through effects on GLUT4, causing insulin resistance.

What to do

Monitor blood glucose and HbA1c when starting or changing the protease inhibitor and increase antidiabetic doses as needed.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fosamprenavir and Insulin glargine-lixisenatide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Fosamprenavir with Insulin glargine-lixisenatide?

MediHelp rates the interaction as moderate. Fosamprenavir and Insulin glargine-lixisenatide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. HIV protease inhibitors can cause insulin resistance and hyperglycemia, which may reduce the glucose-lowering effect of insulin glargine and lixisenatide. Glycemic control may worsen, particularly early in treatment.

How serious is the interaction between Fosamprenavir and Insulin glargine-lixisenatide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose and HbA1c when starting or changing the protease inhibitor and increase antidiabetic doses as needed.

What other medicines interact with Insulin glargine-lixisenatide?

MediHelp also lists interactions of Insulin glargine-lixisenatide with, for example, Albiglutide, Chlorpropamide, Dulaglutide. The full list is on the Insulin glargine-lixisenatide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in